These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19020330)

  • 1. Attenuation by a thousand cuts.
    Coffin JM
    N Engl J Med; 2008 Nov; 359(21):2283-5. PubMed ID: 19020330
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus attenuation by genome-scale changes in codon pair bias.
    Coleman JR; Papamichail D; Skiena S; Futcher B; Wimmer E; Mueller S
    Science; 2008 Jun; 320(5884):1784-7. PubMed ID: 18583614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.
    Mueller S; Papamichail D; Coleman JR; Skiena S; Wimmer E
    J Virol; 2006 Oct; 80(19):9687-96. PubMed ID: 16973573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD; Macadam AJ; Stone DM; Almond JW
    Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
    [No Abstract]   [Full Text] [Related]  

  • 5. The molecular biology of poliovaccines.
    Minor PD
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3065-77. PubMed ID: 1335021
    [No Abstract]   [Full Text] [Related]  

  • 6. Virology. 'Biased' viruses suggest new vaccine strategy for polio and other diseases.
    Enserink M
    Science; 2008 Jun; 320(5884):1709. PubMed ID: 18583587
    [No Abstract]   [Full Text] [Related]  

  • 7. Codon usage determines the mutational robustness, evolutionary capacity, and virulence of an RNA virus.
    Lauring AS; Acevedo A; Cooper SB; Andino R
    Cell Host Microbe; 2012 Nov; 12(5):623-32. PubMed ID: 23159052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
    Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
    J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic stability and instability of the cis-acting control element of the 5' untranslated region of the poliovirus RNA.
    Agol VI
    Dev Biol Stand; 1993; 78():11-6. PubMed ID: 8388821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International workshop: 'poliovirus attenuation: molecular mechanisms and practical aspects'. 9-10 December 1991, Holiday Inn, Bethesda, MD, U.S.A.
    Ehrenfeld E
    Biologicals; 1992 Jun; 20(2):167-9. PubMed ID: 1327006
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
    Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
    Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
    J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
    McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
    J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The attenuation of poliovirus neurovirulence.
    Almond JW
    Annu Rev Microbiol; 1987; 41():153-80. PubMed ID: 2825586
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutational analysis of upstream AUG codons of poliovirus RNA.
    Pelletier J; Flynn ME; Kaplan G; Racaniello V; Sonenberg N
    J Virol; 1988 Dec; 62(12):4486-92. PubMed ID: 2846865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
    Burns CC; Shaw J; Campagnoli R; Jorba J; Vincent A; Quay J; Kew O
    J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
    Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
    Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
    Cello J; Paul AV; Wimmer E
    Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.